Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on March 24, 2025
Aura Minerals Announces Renewal of Normal Course Issuer Bid and Concurrent Buyback Program for Brazilian Depositary Receipts
GlobeNewswire
·
March 24, 2025
ROAD TOWN, British Virgin Islands, March 24, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) ("Aura Minerals" or the "Company") announces today that the Toronto Stock Exchange (the "TSX") has accepted the Company's notice …
FTC Solar to Announce Fourth Quarter and Full Year 2024 Financial Results Monday, March 31, 2025
GlobeNewswire
·
March 24, 2025
AUSTIN, Texas, March 24, 2025 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, today announced it will report its fourth quarter and full year 2024 financial results before …
Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting
GlobeNewswire
·
March 24, 2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
GlobeNewswire
·
March 24, 2025
Boca Raton, Florida, March 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it will host a conference call on Thursday, March 27, 2025, at 4:30pm EDT to …
HealthLynked Announces Enhanced Patient In-Office Booking and Upgrades to ARi Healthcare Assistant
GlobeNewswire
·
March 24, 2025
NAPLES, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on improving patient care, is pleased to announce new features to its in-office online appointment booking platform and …
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
GlobeNewswire
·
March 24, 2025
SAN JOSE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced its Aquablation …
NV5 Awarded $9 Million in Geospatial Utility Contracts to Support Wildfire Mitigation
GlobeNewswire
·
March 24, 2025
HOLLYWOOD, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- NV5, a provider of tech-enabled engineering, certification, and consulting solutions, announced today that it has been awarded $9 million in recent contracts to support wildfire mitigation and resiliency …
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
GlobeNewswire
·
March 24, 2025
Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALS Clene planning to initiate the confirmatory Phase 3 RESTORE-ALS trial in subjects with ALS in mid-2025 Secured new $10.0 …
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
GlobeNewswire
·
March 24, 2025
– Latest BOND-003 data show 75.5% of patients achieved a complete response at any time – – Median duration of response exceeds 28 months and is ongoing – – No close contact precautions needed post cretostimogene treatment – IRVINE, Calif., March 24, 2025 ( …
Kratos Defense & Security Solutions Added to S&P SmallCap 600 Index
GlobeNewswire
·
March 24, 2025
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Kratos Defense …
Algorhythm Holdings to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025 on March 25-26, 2025
GlobeNewswire
·
March 24, 2025
Fort Lauderdale, FL, March 24, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), an AI-driven technology and consumer electronics holding company, today announced that its management will be participating in the iAccess …
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025
GlobeNewswire
·
March 24, 2025
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and well-being of women, will host a conference call and live webcast at 4:30 p.m. Eastern Time on Monday, March 31, 2025, to review …
HII is Awarded Contract to Develop High-Energy Laser Weapon System for the US Army
GlobeNewswire
·
March 24, 2025
MCLEAN, Va., March 24, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Mission Technologies division was selected to develop an open architecture High-Energy Laser (HEL) weapon system for the U.S. Army’s Rapid Capabilities and Critical …
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 24, 2025
Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and cancer Updates expected later this …
FST Corp. Introduces KBS-branded Graphite Golf Shaft Designed to Achieve Greater Shot Distance and Accuracy
GlobeNewswire
·
March 24, 2025
Boulder, CO, March 24, 2025 (GLOBE NEWSWIRE) -- FST Corp. (Nasdaq: KBSX), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced the launch of a graphite shaft engineered to …
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
GlobeNewswire
·
March 24, 2025
On track for August 15, 2025 FDA PDUFA goal date TNX-102 SL is a non-opioid analgesic; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Commercial planning for TNX-102 SL underway for launch in the …
Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules
GlobeNewswire
·
March 24, 2025
WARRINGTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing early and late-stage innovative therapies …
IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
GlobeNewswire
·
March 24, 2025
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3 pivotal trial of DNA-mediated IL-12 therapeutic Company to …
Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 24, 2025
Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial responses SAFEbody technology utilized to create masked T cell engagers for potentially superior safety profile …
Duos Technologies Group Sets Fourth Quarter and Full Year 2024 Earnings Call for Monday March 31, 2025, at 4:30 PM ET
GlobeNewswire
·
March 24, 2025
JACKSONVILLE, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT) will hold a conference call on Monday, March 31, 2025 at 4:30 p.m. Eastern time to discuss its financial results for the fourth …